Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AQ-13 in Uncomplicated P. falciparum Malaria
NCT01614964Phase 2Completed
- Sponsor
- Tulane University
- Start
- Aug 2013
- Primary completion
- Jan 2016
- Countries
- 1
01
Overview
A Phase 2 trial of AQ-13 in malaria, sponsored by Tulane University. Started Aug 2013; status: completed.
02
Drugs
AQ-13
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01614964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01614964.